XBIO
Xenetic Biosciences Inc
NASDAQ: XBIO · HEALTHCARE · BIOTECHNOLOGY
$3.03
+1.00% today
Updated 2026-04-30
Market cap
$6.87M
P/E ratio
—
P/S ratio
2.31x
EPS (TTM)
$-1.58
Dividend yield
—
52W range
$2 – $14
Volume
0.0M
Xenetic Biosciences Inc (XBIO) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-6.26M | $-6.05M | $-12.33M | $-5.30M | $-8.79M | $1.49M | $-6.46M | $-6.40M | $-4.27M | $-4.74M | $-4.65M | $-4.11M | $-2.82M | $-2.29M |
| Capital expenditures | $130084.00 | $78634.00 | $57669.00 | $1663.00 | $16793.00 | $9264.00 | $0.00 | $0.00 | $0.00 | $0.00 | $500000.00 | $1.00 | $0.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $339780.00 | $431504.00 | $1.51M | $2.75M | $2.10M | $1.92M | $1.42M | $853517.00 | $468914.00 | $410437.00 | $511480.00 | $283085.00 | $171814.00 | $64787.00 |
| Free cash flow | $-6.39M | $-6.13M | $-12.39M | $-5.30M | $-8.80M | $1.48M | $-6.46M | $-6.40M | $-4.27M | $-4.74M | $-5.15M | $-4.11M | $-2.82M | $-2.29M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | $39.50M | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | $-6.30M | $-2.33M | $-2.38M | $3.92M | $1.48M | $-4.96M | $9.73M | $1.16M | — | — | — | — | — |